Su Yan

779 total citations
19 papers, 608 citations indexed

About

Su Yan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Su Yan has authored 19 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Su Yan's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Su Yan is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Su Yan collaborates with scholars based in China and United States. Su Yan's co-authors include Jorge H. Capdevila, Shouzuo Wei, Ambra Pozzi, John R. Falck, Roy Zent, Ines Macias‐Perez, Nai‐Kong V. Cheung, Cheng Liu, Tao Dao and Richard J. O’Reilly and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Su Yan

18 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Yan China 11 290 183 135 131 121 19 608
Meghan E. McMullen United States 6 268 0.9× 95 0.5× 44 0.3× 140 1.1× 46 0.4× 8 503
Jürgen Steffgen Germany 14 228 0.8× 145 0.8× 29 0.2× 146 1.1× 32 0.3× 25 639
Shakuntala Kondraganti United States 13 274 0.9× 89 0.5× 28 0.2× 45 0.3× 136 1.1× 15 534
Janna C. Collins United States 12 566 2.0× 104 0.6× 60 0.4× 90 0.7× 48 0.4× 24 867
Omar Moussa United States 19 423 1.5× 140 0.8× 36 0.3× 181 1.4× 203 1.7× 25 828
Yves Communal France 14 328 1.1× 149 0.8× 23 0.2× 44 0.3× 146 1.2× 23 669
Romain Riscal United States 9 492 1.7× 192 1.0× 50 0.4× 75 0.6× 356 2.9× 12 822
Renata Windak Poland 6 413 1.4× 69 0.4× 28 0.2× 65 0.5× 164 1.4× 18 689
Megan D. Hoeksema United States 13 794 2.7× 210 1.1× 215 1.6× 101 0.8× 552 4.6× 13 1.2k
Marie O’Farrell United States 9 486 1.7× 126 0.7× 76 0.6× 59 0.5× 426 3.5× 25 901

Countries citing papers authored by Su Yan

Since Specialization
Citations

This map shows the geographic impact of Su Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Yan more than expected).

Fields of papers citing papers by Su Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Yan. The network helps show where Su Yan may publish in the future.

Co-authorship network of co-authors of Su Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Su Yan. A scholar is included among the top collaborators of Su Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Yan. Su Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Zhao, Xiaoxue, Qiyao Wang, Ting Wang, et al.. (2023). Evaluation of prebiotic ability of xylo-oligosaccharide fractions with different polymerization degrees from bamboo shoot shells. Food and Bioproducts Processing. 143. 202–211. 10 indexed citations
3.
Xu, Yan, et al.. (2022). Identification of HAGHL as a novel metabolic oncogene regulating human colorectal cancer progression. Clinical & Translational Oncology. 25(4). 1033–1042. 2 indexed citations
4.
5.
6.
7.
Xu, Jun, et al.. (2020). Alteration of the abundance of <em>Parvimonas&nbsp;micra</em> in the gut along the adenoma‑carcinoma sequence. Oncology Letters. 20(4). 1–1. 23 indexed citations
8.
Xu, Jian, Su Yan, Aoshuang Xu, et al.. (2018). MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12. Blood. 132(Supplement 1). 4469–4469. 1 indexed citations
9.
Zhang, Shuang, Yubin Ding, Junlin He, et al.. (2018). Altered expression patterns of circular RNAs between implantation sites and interimplantation sites in early pregnant mice. Journal of Cellular Physiology. 234(6). 9862–9872. 17 indexed citations
10.
Tang, Bo, Aoshuang Xu, Jian Xu, et al.. (2017). MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. International Journal of Cancer. 142(1). 109–120. 62 indexed citations
11.
12.
Gao, Fei, Yu‐Qin Zhang, Feng Yang, et al.. (2014). Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP-7. Molecular Medicine Reports. 9(3). 825–830. 12 indexed citations
13.
Yan, Su, et al.. (2014). The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells. International Journal of Molecular Medicine. 34(3). 842–848. 10 indexed citations
14.
Dubrovsky, Leonid, Dmitry Pankov, Elliott J. Brea, et al.. (2014). A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood. 123(21). 3296–3304. 41 indexed citations
15.
Téliz‐Ortíz, Daniel, et al.. (2013). Resuscitation from hemorrhagic shock using polymerized hemoglobin compared to blood. The American Journal of Emergency Medicine. 32(3). 248–255. 23 indexed citations
16.
Liu, Yihui, et al.. (2013). Tumor gangliosides accelerate murine tumor angiogenesis. Angiogenesis. 17(3). 563–571. 35 indexed citations
17.
Dao, Tao, Su Yan, Nicholas Veomett, et al.. (2013). Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody. Science Translational Medicine. 5(176). 176ra33–176ra33. 136 indexed citations
18.
Yan, Su, et al.. (2012). ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy. SHILAP Revista de lepidopterología. 2. 34–34. 60 indexed citations
19.
Pozzi, Ambra, Ines Macias‐Perez, Shouzuo Wei, et al.. (2005). Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids. Journal of Biological Chemistry. 280(29). 27138–27146. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meghan E. McMullen Breakdown of academic impact, for papers by Jürgen Steffgen Breakdown of academic impact, for papers by Shakuntala Kondraganti Breakdown of academic impact, for papers by Janna C. Collins Breakdown of academic impact, for papers by Omar Moussa Breakdown of academic impact, for papers by Yves Communal Breakdown of academic impact, for papers by Romain Riscal Breakdown of academic impact, for papers by Renata Windak Breakdown of academic impact, for papers by Megan D. Hoeksema Breakdown of academic impact, for papers by Marie O’Farrell
Rankless by CCL
2026